Results 171 to 180 of about 31,965 (231)

TMPRSS2/ETS Family Fusion Gene [PDF]

, 2020
openaire   +1 more source

TMPRSS2 inhibitors with broad-spectrum efficacy against SARS-CoV-2 (JN.1) and influenza A (H1N1) viruses protect mice from influenza A infection. [PDF]

Emerg Microbes Infect
Presley L, Pérez-Vargas J, Saintigny A, Villanueva I, Ho M, Fone J, Brinsden L, Kaushik N, Olver S, Thompson CAH, Bautista-Sánchez D, Ennis S, Chen M, McCallum M, Brown JT, Ferková S, Hetrick B, Veesler D, Leduc R, Niikura M, Boudreault PL, Warner B, Jean F.   +22 more
europepmc   +1 more source

Human parainfluenza virus 3 fusion protein cleavage: a key determinant of infection and spread. [PDF]

J Virol
Stearns K, Marcink T, Pawlack E, Sobolik EB, Porotto M, Greninger AL, Nieweisk S, Moscona A.   +7 more
europepmc   +1 more source

Viral mechanisms, tropism, and clinical relevance regarding the ophthalmic manifestations of SARS-CoV-2 infection. [PDF]

Int J Ophthalmol
González S, Arellano J, Reza-Zaldivar EE, Mena-Munguía S, Minjarez B, Rodríguez-Yáñez Y.   +5 more
europepmc   +1 more source

The synergistic interaction between ACE and TMPRSS2 polymorphisms increases the risk of severe COVID-19. [PDF]

PLoS One
Bayaraa O, Ganbold C, Byambadorj B, Battulga Z, Dashtseren I, Jav S.   +5 more
europepmc   +1 more source

Bioactive Compounds of <i>Momordica charantia</i> L. Downregulate the Protein Expression of ACE2 and TMPRSS2 In Vivo and In Vitro. [PDF]

Int J Mol Sci
Chao CY, Shyu WC, Lin CL, Jiang WP, Inose A, Chiang SJ, Wu WL, Lin JG, Huang GJ.   +8 more
europepmc   +1 more source

Efficient production of fully active, SARS-CoV-2-priming, wildtype TMPRSS2 ectodomain via co-expression of HAI-2 allows for both auto- and cross-activation mechanisms. [PDF]

Biochem J
Végh B, Kocsis A, Dobó J, Balczer J, Kiss B, Pál G, Gál P.   +6 more
europepmc   +1 more source

SARS-CoV-2 evolution enhances endocytic uptake while preserving TMPRSS2-dependent fusion. [PDF]

Front Immunol
Magnus CL, Jaber ZH, Hiergeist A, Arnold L, Marchel H, Lamprecht A, Hanses F, Dienemann T, Schneckenpointner R, Lubnow M, Müller T, Lunz D, Hitzenbichler F, Schmid S, Müller M, Poeck H, Graf B, Salzberger B, Gessner A, Schmidt B, Schuster P.   +20 more
europepmc   +1 more source

FOXA1 Alterations in Prostate Cancer: Expression, Mutation Classes, and Copy Number Changes. [PDF]

In Vivo
Lehrer S, Rheinstein P.
europepmc   +1 more source